These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 24210470)

  • 1. Numerical modelling of mass transport in an arterial wall with anisotropic transport properties.
    Denny WJ; Walsh MT
    J Biomech; 2014 Jan; 47(1):168-77. PubMed ID: 24210470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Numerical modelling of the physical factors that affect mass transport in the vasculature at early time periods.
    Denny WJ; Walsh MT
    Med Eng Phys; 2014 Mar; 36(3):308-17. PubMed ID: 24462324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving smooth muscle cell exposure to drugs from drug-eluting stents at early time points: a variable compression approach.
    O'Connell BM; Cunnane EM; Denny WJ; Carroll GT; Walsh MT
    Biomech Model Mechanobiol; 2014 Aug; 13(4):771-81. PubMed ID: 24101254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Demonstrating the influence of compression on artery wall mass transport.
    O'Connell BM; Walsh MT
    Ann Biomed Eng; 2010 Apr; 38(4):1354-66. PubMed ID: 20077008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An analysis of three dimensional diffusion in a representative arterial wall mass transport model.
    Denny WJ; O'Connell BM; Milroy J; Walsh MT
    Ann Biomed Eng; 2013 May; 41(5):1062-73. PubMed ID: 23269495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors that affect mass transport from drug eluting stents into the artery wall.
    O'Connell BM; McGloughlin TM; Walsh MT
    Biomed Eng Online; 2010 Mar; 9():15. PubMed ID: 20214774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How does stent expansion alter drug transport properties of the arterial wall?
    Escuer J; Cebollero M; Peña E; McGinty S; Martínez MA
    J Mech Behav Biomed Mater; 2020 Apr; 104():103610. PubMed ID: 32174384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modelling intravascular delivery from drug-eluting stents with biodurable coating: investigation of anisotropic vascular drug diffusivity and arterial drug distribution.
    Zhu X; Pack DW; Braatz RD
    Comput Methods Biomech Biomed Engin; 2014; 17(3):187-98. PubMed ID: 22512464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug transport in artery walls: a sequential porohyperelastic-transport approach.
    Feenstra PH; Taylor CA
    Comput Methods Biomech Biomed Engin; 2009 Jun; 12(3):263-76. PubMed ID: 18949653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modelling and simulation of low-density lipoprotein transport through multi-layered wall of an anatomically realistic carotid artery bifurcation.
    Kenjereš S; de Loor A
    J R Soc Interface; 2014 Feb; 11(91):20130941. PubMed ID: 24284897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug release from coronary eluting stents: A multidomain approach.
    Vairo G; Cioffi M; Cottone R; Dubini G; Migliavacca F
    J Biomech; 2010 May; 43(8):1580-9. PubMed ID: 20185137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling the transport of drugs eluted from stents: physical phenomena driving drug distribution in the arterial wall.
    Bozsak F; Chomaz JM; Barakat AI
    Biomech Model Mechanobiol; 2014 Apr; 13(2):327-47. PubMed ID: 24395527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of diffusion coefficients and struts apposition using numerical simulations for drug eluting coronary stents.
    Mongrain R; Faik I; Leask RL; Rodés-Cabau J; Larose E; Bertrand OF
    J Biomech Eng; 2007 Oct; 129(5):733-42. PubMed ID: 17887899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Numerical modeling of coronary drug eluting stents.
    Mongrain R; Leask R; Brunette J; Faik I; Bulman-Feleming N; Nguyen T
    Stud Health Technol Inform; 2005; 113():443-58. PubMed ID: 15923752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between catheter-based delivery of paclitaxel after bare-metal stenting and drug-eluting stents in coronary artery disease patients at high risk for in-stent restenosis.
    El-Mokadem M; El-Ramly M; Hassan A; Boshra H; AbdelWahab A
    Cardiovasc Revasc Med; 2017 Dec; 18(8):596-600. PubMed ID: 28625402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of Drug Delivery by Drug-Eluting Stents.
    Bozsak F; Gonzalez-Rodriguez D; Sternberger Z; Belitz P; Bewley T; Chomaz JM; Barakat AI
    PLoS One; 2015; 10(6):e0130182. PubMed ID: 26083626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strut position, blood flow, and drug deposition: implications for single and overlapping drug-eluting stents.
    Balakrishnan B; Tzafriri AR; Seifert P; Groothuis A; Rogers C; Edelman ER
    Circulation; 2005 Jun; 111(22):2958-65. PubMed ID: 15927969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Numerical simulation of stent deployment within patient-specific artery and its validation against clinical data.
    Djukic T; Saveljic I; Pelosi G; Parodi O; Filipovic N
    Comput Methods Programs Biomed; 2019 Jul; 175():121-127. PubMed ID: 31104701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Geometry parameterization and multidisciplinary constrained optimization of coronary stents.
    Pant S; Bressloff NW; Limbert G
    Biomech Model Mechanobiol; 2012 Jan; 11(1-2):61-82. PubMed ID: 21373889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized optical coherence tomography study of coronary stent strut coverage and luminal protrusion with rapamycin-eluting stents.
    Moore P; Barlis P; Spiro J; Ghimire G; Roughton M; Di Mario C; Wallis W; Ilsley C; Mitchell A; Mason M; Kharbanda R; Vincent P; Sherwin S; Dalby M
    JACC Cardiovasc Interv; 2009 May; 2(5):437-44. PubMed ID: 19463468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.